Search

everythinglearnresearchcommunity

for

Search:↓

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Fullerenes show potential in skin care but need more safety research.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

No definitive link between finasteride and male breast cancer, but further research is needed.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Different scalp imaging methods are important for studying hair and scalp health and require more volunteers for better evaluation.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

Treating melasma in men is difficult, especially for the deeper skin layers, and may need more than just topical treatments.

Hair loss causes emotional distress, leading to high spending on treatments, with Minoxidil and Propecia being common but having side effects.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Ginsenoside Rg3 combined with minoxidil was more effective in treating hair loss in mice.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

Most people in Jazan know about vitamin D, zinc, and ferritin's link to hair loss but don't practice enough preventive measures.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

The scalp serum reduced scalp discomfort and symptoms without affecting skin moisture loss.

Hair removal with intense pulsed light can cause rare skin lesions that are hard to fully treat.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Greasy hair spreads sebum twice as much as nongreasy hair over time.